ArticleClinical case reports2021

Complete hematological and major molecular response through treatment with low-dose Interferon alpha 2a in high-risk polycythemia vera patient: a case report.

Christoph Driessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.